1Briguori C,Airoldi F, Morici N, et al. New Pharmacological protocols to prevent or reduce contrast media nephropathy [ J ]. Minerva Cardioangiol, 2005,53( 1 ) :49 - 58.
6Hizoh I, Strater J, Schick CS, et al. Radioconstrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity[J]. Nephrol Dial Transplant, 1998, 13(4):911 -918.
1Kolonko A, Wiecek A. Contrast-associated nephropathy: old clinical problem and new therapeutic perspectives[J]. Nephrol Dial Transplant, 1998,13 : 803-806.
2Manske CL, Sprafka JM, Strony JT, et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography[J]. Am J Med , 1990, 89: 615-620.
3Berg KJ. Nephrotoxicity related to contrast media[J].Scand J Urol Nephrol, 2000,34:317-322.
4Fang L, Sirota R, Ebert T, et al. Low fractional excretion of sodium with contrast media-induced acute renal failure[J]. Arch Intern Med, 1980,140:531-533.
5Betas J, Rudnick M. Radiocontrast media associated nephrotoxicity[J]. Kidney 1992,24:1-5.
7Paul DW, Kristi LB, John CT. Fenoldopam and Nacetylcysteine for the Prevention of Radiographic Contrast Material-Induced Nephropathy[J]. Pharmacotherapy 2003,23:1617-1626.
8Kurnik BR,Allgren RL,Genter FC,et al.Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.Am J Kidney Dis,1998,31:674 -680.
9Nikolsky E,Aymong ED,Dangas G,et al.Radiocontrst nephropathy:identifying the high-risk patient and the implications of exacerbating renal function.Rev Cardiovasc Med,2003,4Suppl 1:S7 -S14.
10Cirit M,Toprak O,Yesil M,et al.Angiotensin -converting enzyme inhibitors as a risk factor for contrast-induced nephropathy.Nephron Clin Pract,2006,104:20-27.
